Search hospitals > Wisconsin > Marshfield

Marshfield Medical Center-Marshfield

Claim this profile
Marshfield, Wisconsin 54449
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Tumors
Conducts research for Breast Cancer
Conducts research for Lymphoma
441 reported clinical trials
28 medical researchers
Photo of Marshfield Medical Center-Marshfield in MarshfieldPhoto of Marshfield Medical Center-Marshfield in MarshfieldPhoto of Marshfield Medical Center-Marshfield in Marshfield

Summary

Marshfield Medical Center-Marshfield is a medical facility located in Marshfield, Wisconsin. This center is recognized for care of Cancer, Leukemia, Tumors, Breast Cancer, Lymphoma and other specialties. Marshfield Medical Center-Marshfield is involved with conducting 441 clinical trials across 790 conditions. There are 28 research doctors associated with this hospital, such as Michelle A. Manalang, Seth O. Fagbemi, Jon M. Brandt, and Adedayo A. Onitilo.

Area of expertise

1Cancer
Global Leader
Marshfield Medical Center-Marshfield has run 163 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Leukemia
Global Leader
Marshfield Medical Center-Marshfield has run 78 trials for Leukemia. Some of their research focus areas include:
Stage II
CD5 positive
Philadelphia chromosome positive

Top PIs

Clinical Trials running at Marshfield Medical Center-Marshfield

Breast Cancer
Prostate Cancer
Cancer
Lung Cancer
Bladder Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Renal Cell Carcinoma
Multiple Myeloma
Squamous Cell Carcinoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Hormone Therapy with or without Radiation

for Breast Cancer

This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Marshfield Medical Center-Marshfield?
Marshfield Medical Center-Marshfield is a medical facility located in Marshfield, Wisconsin. This center is recognized for care of Cancer, Leukemia, Tumors, Breast Cancer, Lymphoma and other specialties. Marshfield Medical Center-Marshfield is involved with conducting 441 clinical trials across 790 conditions. There are 28 research doctors associated with this hospital, such as Michelle A. Manalang, Seth O. Fagbemi, Jon M. Brandt, and Adedayo A. Onitilo.
Where is Marshfield Medical Center-Marshfield located?
**Marshfield Medical Center-Marshfield** - **Address:** 1000 N Oak Ave, Marshfield, WI. - **Directions:** Take the I-94 W and US-51 N to N Central Ave in Marshfield. Head north on N Central Ave and turn right onto W 14th St.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Marshfield Medical Center-Marshfield, contact: - **Phone:** 1-800-782-8581, ext. 9-4475 - **Email:** PACCounselorShared@marshfieldclinic.org - **Address:** Marshfield Clinic Health System Patient Assistance Center, 3Q4 1000 North Oak Avenue Marshfield, WI 54449 For insurance-related inquiries, please refer to the hospital's website for direct contact information.
What insurance does Marshfield Medical Center-Marshfield accept?
Marshfield Medical Center-Marshfield accepts a wide range of insurance plans, including but not limited to HealthPartners, Humana, Network Health, and United Healthcare. They also accept Medicaid HMO Contracts such as Anthem Blue Cross Blue Shield of Wisconsin – BadgerCare Plus and SSI plans, Group Health Cooperative of Eau Claire – BadgerCare Plus and SSI plans, and United Healthcare – BadgerCare Plus and SSI plans, among others. It is crucial to directly verify your coverage and benefits with your insurance carrier, as limitations depend on individual and/or employer group contracts and benefit plans.
What awards or recognition has Marshfield Medical Center-Marshfield received?
Marshfield Medical Center-Marshfield, located in Wisconsin and part of the Marshfield Clinic Health System, is nationally recognized for patient-centered care by the National Committee for Quality Assurance. The Marshfield Clinic Research Institute (MCRI), a division of Marshfield Clinic, also received national recognition in 2019 for its innovative survey tool.